COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea.
COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea.
复制标题
通过对鼻、喉和气管进行有针对性的水合作用,可减轻COVID-19症状。
DOI:
10.1038/s41598-022-08609-y
复制
发表时间:
2022-03-29
影响因子:
4.6
通讯作者:
Edwards DA
中科院分区:
文献类型:
--
作者:
George CE;Scheuch G;Seifart U;Inbaraj LR;Chandrasingh S;Nair IK;Hickey AJ;Barer MR;Fletcher E;Field RD;Salzman J;Moelis N;Ausiello D;Edwards DA
Dehydration of the upper airways increases risks of respiratory diseases from COVID-19 to asthma and COPD. We find in human volunteer studies involving 464 human subjects in Germany, the US, and India that respiratory droplet generation increases by up to 4 orders of magnitude in dehydration-associated states of advanced age (n = 357), elevated BMI-age (n = 148), strenuous exercise (n = 20) and SARS-CoV-2 infection (n = 87), and falls with hydration of the nose, larynx and trachea by calcium-rich hypertonic salts. We also find in a protocol of exercise-induced airway dehydration that hydration of the airways by calcium-rich salts increases oxygenation relative to a non-treatment control (P < 0.05). In a random control study of COVID-19 positive subjects (n = 40), thrice-a-day delivery of the calcium-rich hypertonic salts (active) suppressed respiratory droplet generation by 51% ± 11% and increased oxygen saturation over three days of treatment by 48.08% ± 9.61% (P < 0.001), while no changes were observed in the nasal-saline control group. Self-reported symptoms significantly declined in the active group and did not decline in the control group. Hydration of the upper airways appears promising as a non-drug approach for reducing risks of respiratory diseases such as COVID-19.
登录
查看更多内容
影响因子:
64.5
作者:
Hou, Yixuan J.;Okuda, Kenichi;Baric, Ralph S.
通讯作者:
Baric, Ralph S.
DOI:
10.1073/pnas.1902840116
发表时间:
2019-05-28
影响因子:
11.1
作者:
Kudo, Eriko;Song, Eric;Iwasaki, Akiko
通讯作者:
Iwasaki, Akiko
影响因子:
7.3
作者:
Kumar S;Çalışkan DM;Janowski J;Faist A;Conrad BCG;Lange J;Ludwig S;Brunotte L
通讯作者:
Brunotte L
DOI:
10.1016/s0140-6736(21)00869-2
发表时间:
2021-05-01
期刊:
Lancet (London, England)
影响因子:
--
作者:
Greenhalgh T;Jimenez JL;Prather KA;Tufekci Z;Fisman D;Schooley R
通讯作者:
Schooley R
影响因子:
3.7
作者:
Etzold, Merlin A.;Linden, P. F.;Worster, M. Grae
通讯作者:
Worster, M. Grae